Search

Search Results
Results 841 - 850 of 867 for Chronic fatigue syndrome
  • Brevinor
    Drug - 6 Mar 2023
    Consumer Medicine Information (CMI) about Brevinor (Ethinylestradiol and Norethisterone) intended for persons living in Australia.
  • Brevinor-1
    Drug - 6 Mar 2023
    Consumer Medicine Information (CMI) about Brevinor-1 (Ethinylestradiol and Norethisterone) intended for persons living in Australia.
  • Telzir Tablets
    Drug - 23 Dec 2022
    Consumer Medicine Information (CMI) about Telzir Tablets intended for persons living in Australia.
  • Kiovig
    Drug - 13 Dec 2022
    Consumer Medicine Information (CMI) about Kiovig intended for persons living in Australia.
  • Ribomustin
    Drug - 17 Oct 2022
    Consumer Medicine Information (CMI) about Ribomustin (Bendamustine Hydrochloride) intended for persons living in Australia.
  • Rixadone
    Drug - 8 Sep 2022
    Consumer Medicine Information (CMI) about Rixadone (risperidone) intended for persons living in Australia.
  • Accupril
    Drug - 2 Sep 2022
    Consumer Medicine Information (CMI) about Accupril intended for persons living in Australia.
  • Inqovi
    Drug - 27 Jul 2022
    Consumer Medicine Information (CMI) about Inqovi intended for persons living in Australia.
  • Valdoxan
    Drug - 31 May 2022
    Consumer Medicine Information (CMI) about Valdoxan intended for persons living in Australia.
  • Domion
    Drug - 31 May 2022
    Consumer Medicine Information (CMI) about Domion intended for persons living in Australia.

Terms

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

Provide Feedback